Covid-19 rapid antigen tests are seeing massive revenue growth. The popularity of these tests can be attributed to their ease ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede ...

Ausria, a radioimmunoassay test to detect serum hepatitis, was launched in 1972 and marked the beginning of Abbott's immunodiagnostics business. A year later, the Abbott Diagnostics Division was ...

The ABBOTT PRISM system is intended for in vitro diagnostic use only. A high throughput, highly automated test system for blood screening: The ABBOTT PRISM is a fully automated, high-volume blood ...

Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. However, Abbott is facing a challenging business environment globally. ABT currently carries a ...